Please login to the form below

Not currently logged in
Email:
Password:

Ian Read

This page shows the latest Ian Read news and features for those working in and with pharma, biotech and healthcare.

Is AstraZeneca looking for its next CEO?

Is AstraZeneca looking for its next CEO?

If Soriot does want to move on, there aren’t likely to be many vacancies in big pharma any time soon: Pfizer has just announced that Albert Bourla will succeed Ian ... Read as CEO, and Merck &Co have just changed their rules to allow Ken Frazier to

Latest news

  • New Pfizer boss shakes up leadership team New Pfizer boss shakes up leadership team

    Albert Bourla, incoming Pfizer CEO. Bourla was revealed as CEO less than two weeks ago, after current boss Ian Read announced he would step down from the role after eight years ... Bourla said: “We are at a pivotal moment in Pfizer’s history, with

  • Pfizer names next CEO as Read retires Pfizer names next CEO as Read retires

    The company’s board of directors unanimously elected Dr. Albert Bourla, Pfizer's current Chief Operating Officer (COO), to succeed Ian Read as CEO from 1 January, 2019. ... Ian Read has been at the helm since December 2010, and will now move into the

  • AstraZeneca chief on Brexit: “it’s going to be really painful” AstraZeneca chief on Brexit: “it’s going to be really painful”

    footing. Yet despite the turnaround he has faced two shareholder revolts over renumeration  and his pay lags behind those of other CEOs such as Pfizer’s Ian Read and Gilead’s

  • Novartis sells off part of Sandoz portfolio Novartis sells off part of Sandoz portfolio

    This stemmed from US president Donald Trump publicly criticising Pfizer CEO Ian Read over the company’s 2018 proposed price increases.

  • Pfizer CEO reckons rebates will disappear, and that’s a positive Pfizer CEO reckons rebates will disappear, and that’s a positive

    Pfizer’s chief executive Ian Read (pictured below) has said that he expects drug price rebates will eventually disappear in the US, and that could give drugs like arthritis drug Xeljanz ... formulary is offering a large rebate – something that Read

More from news
Approximately 1 fully matching, plus 59 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Bourla was revealed as CEO in early October, after current boss Ian Read announced he would step down from the role after eight years of service. ... Bourla said: “We are at a pivotal moment in Pfizer’s history, with Ian Read having positioned the

  • Pharma deals continue to slide Pharma deals continue to slide

    At the beginning of the month this was confirmed by Ian Read, CEO of Pfizer. ... During the second quarter earnings call Read said: “We look at BD (business development) as a way of improving returns for shareholders.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Pfizer names Albert Bourla as COO Pfizer names Albert Bourla as COO

    vaccines. Ian Read, chairman and CEO, Pfizer, said: “Albert is a proven and trusted leader with over two decades of leadership experience and a demonstrated track record for delivering strong business

  • Pfizer strengthens board of directors Pfizer strengthens board of directors

    Ian Read, Pfizer's chairman and chief executive officer, said: “ We are pleased to welcome Ron Blaylock to Pfizer's board of directors. “

  • IFPMA appoints director general IFPMA appoints director general

    Ian Read, IFPMA's president and chief executive and chairman of Pfizer, said: “ Thomas has extensive experience in the research-based biopharmaceutical industry and a deep understanding of what is needed

  • IFPMA elects Pfizer’s Ian Read as president IFPMA elects Pfizer’s Ian Read as president

    IFPMA elects Pfizer’ s Ian Read as president. Read succeeds Merck KGaA’ s Dr Stefan Oschmann for a two-year term. ... The International Federation of Pharmaceutical Manufacturers &Associations (IFPMA) has elected Pfizer's Ian Read as its new president

  • Adobe CEO joins Pfizer board Adobe CEO joins Pfizer board

    The addition of Shantanu Narayen to our board helps ensure that Pfizer will continue to benefit from a diversity of experience,” said Ian Read, Pfizer's chairman and CEO.

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics